SPC
GILD icon

Stewart & Patten Company’s Gilead Sciences GILD Stock Holding History

Stewart & Patten Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,450
Closed -$204K – 91
2016
Q2 		$204K Sell
2,450
-6
-0.2% -$532 0.04% 87
2016
Q1 		$226K Hold
2,456
– – 0.05% 81
2015
Q4 		$249K Hold
2,456
– – 0.05% 79
2015
Q3 		$241K Hold
2,456
– – 0.05% 80
2015
Q2 		$288K Buy
2,456
+56
+2% +$6.12K 0.06% 80
2015
Q1 		$236K Hold
2,400
– – 0.05% 85
2014
Q4 		$226K Sell
2,400
-90
-4% -$9.31K 0.04% 91
2014
Q3 		$265K Hold
2,490
– – 0.05% 83
2014
Q2 		$206K Buy
+2,490
New +$194K 0.04% 89

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stewart & Patten Company's GILD Position: Q3 2016 in Review

Stewart & Patten Company sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 2,450 shares — an estimated $204K sold.

Stewart & Patten Company first reported a position in GILD in Q2 2014 and held it in 9 quarters. The position peaked at $288K in Q2 2015. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Stewart & Patten Company reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Stewart & Patten Company sold 2,450 Gilead Sciences shares in Q3 2016, an estimated $204K.
  • Stewart & Patten Company first reported a position in Gilead Sciences in Q2 2014 and held it in 9 quarters.
  • Stewart & Patten Company's Gilead Sciences position peaked at $288K in Q2 2015.
  • 1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Stewart & Patten Company's 13F filing for Q3 2016, filed 18 Oct 2016.